Skip to main content
. 2020 Aug 26;10:14204. doi: 10.1038/s41598-020-70921-2

Table 2.

Modified minimum inhibitory concentration of vancomycin, meropenem, and ciprofloxacin upon administration with sCur (8 µg/ml) against MDR pathogens.

Isolates Vancomycin modified MIC (µg/ml) Meropenem modified MIC (µg/ml) Ciprofloxacin modified MIC (µg/ml)
Staphylococcus aureus (MRSA, 2,862/2019) 0.25 1
Klebsiella pneumoniae (10,825/2019) 16 2 2
Escherichia coli (507/2019) 8 1 1
Pseudomonas aeruginosa (2,412/2019) 16 4 2